# IVIM & OLINK in Sarcoma

> **NCT05950594** · PHASE2 · RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 145 (estimated)

## Conditions studied

- Soft Tissue Sarcoma

## Interventions

- **RADIATION:** Radiotherapy
- **OTHER:** Surgery

## Key facts

- **NCT ID:** NCT05950594
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-05
- **Primary completion:** 2027-11-30
- **Final completion:** 2027-11-30
- **Target enrollment:** 145 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05950594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05950594, "IVIM & OLINK in Sarcoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05950594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*